| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |